Abstract
Background Compartmental models dominate epidemic modeling. Estimations of transmission parameters between compartments are typically done through stochastic parameterization processes that depend upon detailed statistics on transmission characteristics, which are economically and resource-wide expensive to collect. We apply deep learning techniques as a lower data dependency alternative to estimate transmission parameters of a customized compartmental model, for the purposes of simulating the dynamics of the US COVID-19 epidemics and projecting its further development.
Methods We construct a compartmental model. We develop a multistep deep learning methodology to estimate the model’s transmission parameters. We then feed the estimated transmission parameters to the model to predict the development of the US COVID-19 epidemics for 35 and 42 days. Epidemics are considered suppressed when the basic reproduction number (R0) becomes less than one.
Results The deep learning-enhanced compartmental model predicts that R0 will become less than one around June 19 to July 3, 2020, at which point the epidemics will effectively start to die out, and that the US “Infected” population will peak round June 18 to July 2, 2020 between 1·34 million and 1·41 million individual cases. The models also predict that the number of accumulative confirmed cases will cross the 2 million mark around June 10 to 11, 2020.
Conclusions Current compartmental models require stochastic parameterization to estimate the transmission parameters. These models’ effectiveness depends upon detailed statistics on transmission characteristics. As an alternative, deep learning techniques are effective in estimating these stochastic parameters with greatly reduced dependency on data particularity.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
NA
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
NA
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Data Availability
Up-to-date time series data available up request.
